SCHEMBL1494443

SCHEMBL1494443

Cc1ccc(OCBr)cc1[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.51
TSHR P16473 2/20 0.51
CYP3A4 P08684 1/20 0.51
RECQL P46063 1/20 0.51
MAPT P10636 8/20 0.48
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
LMNA P02545 2/20 0.47
HSD17B10 Q99714 1/20 0.44
HPGD P15428 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14419426 0.87 MAPT (0.52) ALDH1A1TSHRCYP3A4RECQLMAPT
SCHEMBL3721960 0.86 MAPT (0.64) ALDH1A1TSHRCYP3A4RECQLMAPT
SCHEMBL246285 0.86 MAPT (0.54) ALDH1A1TSHRCYP3A4RECQLMAPT
SCHEMBL28674209 0.85 MAPT (0.53) ALDH1A1TSHRCYP3A4RECQLMAPT
SCHEMBL13301370 0.83 ALDH1A1 (0.49) ALDH1A1TSHRCYP3A4RECQLMAPT
SCHEMBL4228943 0.83 MAPT (0.66) ALDH1A1TSHRCYP3A4RECQLMAPT
SCHEMBL30178231 0.83 ALDH1A1 (0.49) ALDH1A1TSHRCYP3A4RECQLMAPT
SCHEMBL4257371 0.83 MAPT (0.57) ALDH1A1TSHRCYP3A4RECQLMAPT
SCHEMBL16665240 0.82 MAPT (0.50) ALDH1A1TSHRCYP3A4RECQLMAPT
SCHEMBL5465073 0.82 MAPT (0.50) ALDH1A1TSHRCYP3A4RECQLMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2470528-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS Novartis AG (CH) 2012-07-04 EP disclosed
WO-2011023773-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS NOVARTIS AG (CH) 2011-03-03 WO disclosed